These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 20074160)

  • 21. Characteristics of serious complicated gastroduodenal ulcers in Japan.
    Ishikawa S; Inaba T; Mizuno M; Miyake Y; Okada H; Ishikawa H; Hori K; Wato M; Kawai K; Yamamoto K
    Hepatogastroenterology; 2012; 59(113):147-54. PubMed ID: 22251530
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Rabeprazole reduces the recurrence risk of peptic ulcers associated with low-dose aspirin in patients with cardiovascular or cerebrovascular disease: a prospective randomized active-controlled trial.
    Sanuki T; Fujita T; Kutsumi H; Hayakumo T; Yoshida S; Inokuchi H; Murakami M; Matsubara Y; Kuwayama H; Kawai T; Miyaji H; Fujisawa T; Terao S; Yamazaki Y; Azuma T;
    J Gastroenterol; 2012 Nov; 47(11):1186-97. PubMed ID: 22526273
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Nonsteroidal antiinflammatory drug-induced mucosal lesions of the upper gastrointestinal tract and their relationship to Helicobacter pylori.
    Rybár I; Masaryk P; Mateicka F; Kopecký S; Rovenský J
    Int J Clin Pharmacol Res; 2001; 21(3-4):119-25. PubMed ID: 12067141
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Gastro-duodenal mucosal changes associated with low-dose aspirin therapy: a prospective, endoscopic study.
    Chowdhury A; Ganguly G; Chowdhury D; Santra A; Gupta JD; Roy T
    Indian J Gastroenterol; 2001; 20(6):227-9. PubMed ID: 11817775
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Multinational, double-blind, randomised, placebo-controlled, prospective study of esomeprazole in the prevention of recurrent peptic ulcer in low-dose acetylsalicylic acid users: the LAVENDER study.
    Sugano K; Choi MG; Lin JT; Goto S; Okada Y; Kinoshita Y; Miwa H; Chiang CE; Chiba T; Hori M; Fukushima Y; Kim HS; Chang CY; Date M;
    Gut; 2014 Jul; 63(7):1061-8. PubMed ID: 24326741
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Endoscopic changes in the stomach and duodenal mucosa caused by minidose acetylsalicylic acid therapy and their prevention].
    Novotný I; Díte P; Kunovská M; Münzová H
    Vnitr Lek; 2007 Oct; 53(10):1053-6. PubMed ID: 18072429
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A case-control study of the risk of upper gastrointestinal mucosal injuries in patients prescribed concurrent NSAIDs and antithrombotic drugs based on data from the Japanese national claims database of 13 million accumulated patients.
    Sugisaki N; Iwakiri R; Tsuruoka N; Sakata Y; Shimoda R; Fujimoto S; Eguchi Y; Fujimoto K
    J Gastroenterol; 2018 Dec; 53(12):1253-1260. PubMed ID: 29948304
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Gastroduodenal mucosa and dyspeptic symptoms in arthritic patients during chronic nonsteroidal anti-inflammatory drug use.
    Larkai EN; Smith JL; Lidsky MD; Graham DY
    Am J Gastroenterol; 1987 Nov; 82(11):1153-8. PubMed ID: 3499815
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Investigation of gastric and duodenal mucosal defects caused by low-dose aspirin in patients with ischemic heart disease.
    Nema H; Kato M; Katsurada T; Nozaki Y; Yotsukura A; Yoshida I; Sato K; Kawai Y; Takagi Y; Okusa T; Takiguchi S; Sakurai M; Asaka M
    J Clin Gastroenterol; 2009 Feb; 43(2):130-2. PubMed ID: 18779739
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Open access gastroscopy findings are unrelated to the use of aspirin and non-steroidal anti-inflammatory drugs.
    Mansfield JC; Greenaway JR; Contractor BR; Idle N; Bramble MG
    Br J Gen Pract; 1997 Dec; 47(425):825-6. PubMed ID: 9463986
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Geographic differences in low-dose aspirin-associated gastroduodenal mucosal injury.
    Iijima K; Shimosegawa T
    World J Gastroenterol; 2015 Jul; 21(25):7709-17. PubMed ID: 26167071
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Endoscopic findings of low-dose aspirin associated ulcers].
    Miyake K; Kusunoki M; Sakamoto C
    Nihon Rinsho; 2010 Nov; 68(11):2031-5. PubMed ID: 21061528
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Low-dose aspirin-associated upper gastric and duodenal ulcers in Japanese patients with no previous history of peptic ulcers.
    Kawamura N; Ito Y; Sasaki M; Iida A; Mizuno M; Ogasawara N; Funaki Y; Kasugai K
    BMC Res Notes; 2013 Nov; 6():455. PubMed ID: 24215903
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Gastric injury caused by low-dose aspirin therapy in consecutive Japanese patients: a prospective study.
    Fukuda S; Hosaka S; Ozawa N; Akita S; Kashima T; Kimura S; Akiyama J; Mizoue T
    Gen Thorac Cardiovasc Surg; 2012 May; 60(5):275-9. PubMed ID: 22453536
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Esophageal mucosal injury with low-dose aspirin and its prevention by rabeprazole.
    Sugimoto M; Nishino M; Kodaira C; Yamade M; Ikuma M; Tanaka T; Sugimura H; Hishida A; Furuta T
    J Clin Pharmacol; 2010 Mar; 50(3):320-30. PubMed ID: 19940233
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Diagnosis and treatment of aspirin--and NSAID-induced peptic ulcers].
    Satoh K; Tanabe H; Ichiishi E; Ando K
    Nihon Rinsho; 2015 Jul; 73(7):1110-5. PubMed ID: 26165066
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Predictors of gastroduodenal erosions in patients taking low-dose aspirin.
    Hart J; Hawkey CJ; Lanas A; Naesdal J; Talley NJ; Thomson AB; Yeomans ND
    Aliment Pharmacol Ther; 2010 Jan; 31(1):143-9. PubMed ID: 19709095
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of Helicobacter pylori eradication on anti-thrombotic dose aspirin-induced gastroduodenal mucosal injury.
    Giral A; Ozdogan O; Celikel CA; Tozun N; Ulusoy NB; Kalayci C
    J Gastroenterol Hepatol; 2004 Jul; 19(7):773-7. PubMed ID: 15209624
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Impact of non-steroidal anti-inflammatory drug and aspirin use on the prevalence of dyspepsia and uncomplicated peptic ulcer disease.
    Voutilainen M; Mäntynen T; Färkkilä M; Juhola M; Sipponen P
    Scand J Gastroenterol; 2001 Aug; 36(8):817-21. PubMed ID: 11495076
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prevalence of gastroduodenal ulcers/erosions in patients taking low-dose aspirin with either 15 mg/day of lansoprazole or 40 mg/day of famotidine: the OITA-GF study 2.
    Tamura A; Murakami K; Kadota J;
    BMC Res Notes; 2013 Mar; 6():116. PubMed ID: 23531145
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.